Rachael C Adams1,2,3*, Dylan Carter-Cusack3*, Genesis T Llanes3*, Christopher R Hunter3*, Janaki Manoja Vinnakota, PhD2,4*, Marc Ruitenberg, PhD5*, Jana Vukovic, PhD5,6*, Patrick Bertolino, PhD7*, Kirat K. Chand, PhD8*, Julie A. Wixey, PhD8,9*, Samuel P Nayler, PhD3*, Geoffrey R Hill, MD10,11, Scott N Furlan, MD12*, Robert Zeiser, MD2,13,14 and Kelli PA MacDonald, PhD3*
1Faculty of Medicine, The University of Queensland, Brisbane, Australia
2Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany
3QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
4Albert-Ludwigs University, Faculty of Biology, Freiburg im Bresigau, Germany
5School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Australia
6Queensland Brain Institute, The University of Queensland, Brisbane, Australia
7Royal Prince Alfred Hospital, Centenary Institute and University of Sydney, AW Morrow Gastroenterology and Liver Centre, Newtown, Australia
8UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia
9Perinatal Research Centre, Royal Brisbane and Women’s Hospital, The University of Queensland, Brisbane, Australia
10Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
11Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
12Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
13University of Freiburg, CIBSS – Centre for Integrative Biological Signalling Studies, Freiburg im Bresigau, Germany
14German Cancer Consortium (DKTK), Partner site Freiburg; and German Cancer Research Center (DKFZ), Heidelberg, Germany